Work

ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.tps8052

Authors: Shaji Kumar, Zihan Wei, Michael A. Thompson, Bradley Snyder, Matthias Weiss, Lynne I. Wagner, Lale Kostakoglu, S. Vincent Rajkumar

Institutions: Mayo Clinic, Dana-Farber Cancer Institute, Aurora Health Care, Brown University, ThedaCare, Wake Forest University Health Sciences, Wake Forest University, University of Virginia

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3170108334

Cites:

Cited by: 3

Related to: 10